Aquarius part of collaborative NIHR grant to evaluate Odin Vision’s artificial intelligence technology to fight bowel cancer

In the UK, 42,000 new diagnoses and 16,000 deaths occur from bowel cancer each year. Bowel cancer is the second most common cause of cancer death in the UK, comprising over 10% of all deaths due to cancer. (1)

A recent study found that almost one third of bowel cancer patients experience an avoidable delay in their diagnosis. (2) Earlier detection of bowel cancer can result in better patient outcomes.  With the goal of achieving earlier diagnosis of cancer and saving more lives, the NIHR AI in Health and Care Award was announced by the Health Secretary, the Rt Hon Matt Hancock MP, at London Tech Week. The National Institue for Health research (NIHR) has awarded £140M in funding to back development of the most promising technologies in artificial intelligence (AI).  Odin Vision Ltd was awarded a grant to support the development of their new AI technology, the CADDIE system, which uses machine learning to assist doctors in identifying and removing abnormalities during a colonoscopy. (3)

Continue reading

Aquarius supports the Royal Marsden as they assess an innovative device for breast cancer surgery

In the latest episode of the BBC’s show, “Trust me, I’m a Doctor”, an innovative new product called Magseed is being trialled to improve surgery for women with breast cancer. A tiny magnetic seed is being used to transform how cancerous tissue is localised so that it can be removed, rather than using traditional guide wires. This helps the surgeons pinpoint exactly where they need to operate, and which angle is the best to approach the tumour. Much smaller tumours are currently being detected through the breast cancer screening programme, which are more difficult to find during surgery using guide wires.

Continue reading

Aquarius Population Health presents the breast cancer diagnostic pathway at ISPOR Milan

Our Managing Director, Dr Elisabeth Adams, will be presenting “Mapping the diagnostic pathway for breast cancer in England and comparison to Europe” at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Milan event which runs from the 7 – 11 November, 2015.

Continue reading

Rapid on-demand testing of HPV and cervical cancer prevention: IPV Conference in Lisbon

Our managing director, Dr Elisabeth Adams, is presenting two posters at the 30th annual International Papillomavirus Conference  in Lisbon, Portugal.  The first poster, “Exploring the value of a rapid, on-demand test for the detection of human papillomavirus”, is a detailed look at the current patient pathways for cervical screening programmes, and key opinion leaders’ views on the impact a rapid diagnostic would have on the health and overall wellbeing of women.

Continue reading

Cancer

Optimising cancer pathways

Pathways for the diagnosis, treatment and follow-up of patients with cancer are complex. Cancer care information is held in different sites, making a holistic view to care challenging. We visualise the different routes to diagnosis and treatment, and quantify the burden to the healthcare system.  This provides a more complete understanding of the opportunities for introducing innovation and improvement into cancer care resulting in better outcomes for patients and more efficient services.

Read more